home / stock / abvc / abvc news


ABVC News and Press, ABVC BioPharma Inc. From 11/01/21

Stock Information

Company Name: ABVC BioPharma Inc.
Stock Symbol: ABVC
Market: NASDAQ
Website: abvcpharma.com

Menu

ABVC ABVC Quote ABVC Short ABVC News ABVC Articles ABVC Message Board
Get ABVC Alerts

News, Short Squeeze, Breakout and More Instantly...

ABVC - ABVC BioPharma, ANI Pharmaceuticals leads healthcare gainers; Centessa Pharmaceuticals, Mirati Therapeutics among major losers

Gainers: ABVC BioPharma (NASDAQ:ABVC) +250%, ANI Pharmaceuticals (NASDAQ:ANIP) +51%, Artelo Biosciences (NASDAQ:ARTL) +37%, Nutriband (NTRBW) +34%, Regencell Bioscience (NASDAQ:RGC) +15%. Losers: Centessa Pharmaceuticals (NASDAQ:CNTA) -19%, Mi...

ABVC - ABVC Biopharma stock is up 275% on Monday: explained here

Shares of ABVC Biopharma Inc (NASDAQ: ABVC) are on fire this morning. The stock jumped nearly 300% on Monday as retail traders on StockTwits picked ABVC Biopharma as their next favourite. ABVC’s trading volume is up significantly The sharp increase from $2.55 a share ...

ABVC - Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Welcome back, investor! We’re starting off the trading week with a breakdown of the biggest pre-market stock movers for Monday! Source: Eric Urquhart/Shutterstock.com We’ve got stocks running higher on...

ABVC - ABVC Biopharma rises fourfold amid social media buzz

ABVC Biopharma (NASDAQ:ABVC) has climbed more than ~400% in the pre-market in a move attributed to strong retail investor interest on the trading social network StockTwits. About 3.7M ABVC (ABVC) shares have changed hands, more than double the 65-day average of ~1.8M shares. Th...

ABVC - Central IRB Approved for ABV-1505 Phase II Part II in Taiwan Sites

ABVC BioPharma Receives Taiwan Regulatory Approval for ABV-1505 ADHD Phase II Part 2 Clinical Study Completion of the Study Expected by the End of 2022 Fremont, CA - ( NewMediaWire ) - October 27, 2021 - ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company de...

ABVC - Jasper Therapeutics, 23andMe leads healthcare gainers; Grove, Myomo among major losers

Gainers: Jasper Therapeutics (NASDAQ:JSPR) +22%, 23andMe (NASDAQ:ME) +21%, DBV Technologies (NASDAQ:DBVT) +10%, ABVC BioPharma (NASDAQ:ABVC) +10%, Sonoma Pharmaceuticals (NASDAQ:SNOA) +8% Losers: Grove (NASDAQ:GRVI) -12%, Myomo (NYSE:MYO) -11%...

ABVC - RIOT, BTBT and HUT among pre market gainers

LM Funding America (NASDAQ:LMFA) +45%. Sonoma Pharmaceuticals SNOA +31% with extended approval for Nanocyn in Australia ABVC BioPharma (NASDAQ:ABVC) +23%. Companhia Brasileira de Distribuicao (NYSE:CBD) +14%. Avadel Pharmaceuticals (NASDAQ:AVDL) +13%. Checkmate Pharmaceuticals CMPI&...

ABVC - Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! It’s the final day of the week and we’re starting the end with a look at the biggest pre-market stock movers for Friday! Source: Shutterstock Investors have earnings reports, new ...

ABVC - FRO, TGB and PLG among pre market gainers

NRx Pharmaceuticals (NASDAQ:NRXP) +36% on positive aviptadil data in Critical COVID-19 KORE Wireless (NYSE:KORE) +35%. TSR (NASDAQ:TSRI) +31% on Q1 earnings. Grove (NASDAQ:GRVI) +21 on launch of Amazon aggregation division Cemtrex (NASDAQ:CETX) +21%. Offerpad Solutions (NY...

ABVC - ABVC BioPharma Restructures Joint Venture to Expand Access to Early-Stage Research

Restructured Venture Also Seeks Licensing Partners for ABVC Fremont, CA - ( NewMediaWire ) - October 12, 2021 - ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced ...

Previous 10 Next 10